Trademark: 90537393
Status Date
Thursday, December 14, 2023
Filing Date
Saturday, February 20, 2021
Published for Opposition
Tuesday, October 19, 2021
5 Pharmaceutical preparations and substances, namely, antibodies for the treatment of cancer, Immunotherapy-related toxicity, and COVID-19
1 Chemical, biochemical and biotechnological preparations used in industry and science, namely, antibodies and fragments of antibodies for use in the manufacture of pharmaceutical preparations
Dec 16, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 14, 2023
Sou Extension 4 Granted
Dec 14, 2023
Sou Extension 4 Filed
Dec 14, 2023
Sou Teas Extension Received
Aug 15, 2023
Assigned To Examiner
May 24, 2023
Notice Of Approval Of Extension Request E-Mailed
May 22, 2023
Sou Extension 3 Granted
May 22, 2023
Sou Extension 3 Filed
May 22, 2023
Sou Teas Extension Received
Dec 7, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 5, 2022
Sou Extension 2 Granted
Dec 5, 2022
Sou Extension 2 Filed
Dec 5, 2022
Sou Teas Extension Received
May 12, 2022
Notice Of Approval Of Extension Request E-Mailed
May 10, 2022
Sou Extension 1 Granted
May 10, 2022
Sou Extension 1 Filed
May 10, 2022
Sou Teas Extension Received
Dec 14, 2021
Noa E-Mailed - Sou Required From Applicant
Oct 19, 2021
Official Gazette Publication Confirmation E-Mailed
Oct 19, 2021
Published For Opposition
Sep 29, 2021
Notification Of Notice Of Publication E-Mailed
Sep 13, 2021
Approved For Pub - Principal Register
Sep 9, 2021
Assigned To Examiner
May 21, 2021
New Application Office Supplied Data Entered
Feb 24, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
